Pfizer’s New Head Of Orphan And Genetic Diseases Looks To Shake Up The Big Pharma Problem-Solving Model
This article was originally published in The Pink Sheet Daily
Executive Summary
Pfizer’s new head of orphan and genetic diseases, Kevin Lee, aims to build a capability within the Big Pharma that is specifically focused on rare diseases, employing a “partner by first intent” problem solving philosophy that reaches across other internal units and across the scientific community.